Molecular analysis of the TGF-beta controlled gene expression program in chicken embryo dermal myofibroblasts

Gene

Volumn 513, Issue 1, 2013, Pages 90-100

  Kosla, Jan ^a   Dvorak, Michal ^a   Cermak, Vladimir ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

Inhibition of TGF beta signaling; Microarray; Myofibroblastic phenotype

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; EXTRACELLULAR SUPEROXIDE DISMUTASE; INTERLEUKIN 6; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; PLACENTAL GROWTH FACTOR; PROTEIN; PROTEIN ADCY2; PROTEIN AGTR2; PROTEIN DNER; PROTEIN FAM180A; PROTEIN FIBIN; PROTEIN MTUS1; PROTEIN NPR3; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; MOLECULAR MECHANICS; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKIN CELL;

ANIMALS; CELLS, CULTURED; CHICK EMBRYO; CHICKENS; DERMIS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MYOFIBROBLASTS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

MAMMALIA; VERTEBRATA;

EID: 84872408478     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.10.069     Document Type: Article

References (44)

1. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med. 2000, 161:646-664.
2. Baarsma H.A., et al. Activation of WNT/beta-catenin signaling in pulmonary fibroblasts by TGF-beta is increased in chronic obstructive pulmonary disease. PLoS One 2011, 6:e25450.
3. Brunner A.M., Marquardt H., Malacko A.R., Lioubin M.N., Purchio A.F. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor. Expression and characterization of mutant proteins. J. Biol. Chem. 1989, 264:13660-13664.
4. Carmeliet P., et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 2001, 7:575-583.
5. Cermak V., Kosla J., Plachy J., Trejbalova K., Hejnar J., Dvorak M. The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells. Cell. Mol. Life Sci. 2010, 67:3557-3568.
6. Chuang P.T., Kawcak T., McMahon A.P. Feedback control of mammalian Hedgehog signaling by the Hedgehog-binding protein, Hip1, modulates Fgf signaling during branching morphogenesis of the lung. Genes Dev. 2003, 17:342-347.
7. Darragh J., et al. MSKs are required for the transcription of the nuclear orphan receptors Nur77, Nurr1 and Nor1 downstream of MAPK signalling. Biochem. J. 2005, 390:749-759.
8. De Wever O., Demetter P., Mareel M., Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int. J. Cancer 2008, 123:2229-2238.
9. Fang W., Hartmann N., Chow D.T., Riegel A.T., Wellstein A. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. J. Biol. Chem. 1992, 267:25889-25897.
10. Fox R.M., Hanlon C.D., Andrew D.J. The CrebA/Creb3-like transcription factors are major and direct regulators of secretory capacity. J. Cell Biol. 2010, 191:479-492.
11. Fuerstenberg S.M., Vennstrom B. Versatile avian retrovirus vectors. Anal. Biochem. 1993, 209:375-376.
12. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 2003, 200:500-503.
13. Gao F., Kinnula V.L., Myllarniemi M., Oury T.D. Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid. Redox Signal. 2008, 10:343-354.
14. Gharaee-Kermani M., Hu B., Phan S.H., Gyetko M.R. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast. Curr. Med. Chem. 2009, 16:1400-1417.
15. Habashi J.P., et al. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 2011, 332:361-365.
16. Hecker L., Jagirdar R., Jin T., Thannickal V.J. Reversible differentiation of myofibroblasts by MyoD. Exp. Cell Res. 2011, 317:1914-1921.
17. Himly M., Foster D.N., Bottoli I., Iacovoni J.S., Vogt P.K. The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Virology 1998, 248:295-304.
18. Hinz B. Formation and function of the myofibroblast during tissue repair. J. Invest. Dermatol. 2007, 127:526-537.
19. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., Gabbiani G. The myofibroblast: one function, multiple origins. Am. J. Pathol. 2007, 170:1807-1816.
20. Jobling A.I., Gentle A., Metlapally R., McGowan B.J., McBrien N.A. Regulation of scleral cell contraction by transforming growth factor-beta and stress: competing roles in myopic eye growth. J. Biol. Chem. 2009, 284:2072-2079.
21. Jun J.I., Lau L.F. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat. Cell Biol. 2010, 12:676-685.
22. Kalogeropoulos M., et al. Zic1 transcription factor in bone: neural developmental protein regulates mechanotransduction in osteocytes. FASEB J. 2010, 24:2893-2903.
23. Kapoun A.M., et al. B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ. Res. 2004, 94:453-461.
24. Kojima Y., et al. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:20009-20014.
25. Kubo H., et al. Identification of mesenchymal stem cell (MSC)-transcription factors by microarray and knockdown analyses, and signature molecule-marked MSC in bone marrow by immunohistochemistry. Genes Cells 2009, 14:407-424.
26. Lanning D.A., Diegelmann R.F., Yager D.R., Wallace M.L., Bagwell C.E., Haynes J.H. Myofibroblast induction with transforming growth factor-beta1 and -beta3 in cutaneous fetal excisional wounds. J. Pediatr. Surg. 2000, 35:183-187. (discussion 187-8).
27. Lin X., Liang M., Feng X.H. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling. J. Biol. Chem. 2000, 275:36818-36822.
28. Lowe C.E., O'Rahilly S., Rochford J.J. Adipogenesis at a glance. J. Cell Sci. 2011, 124:2681-2686.
29. Maeda T., Alexander C.M., Friedl A. Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells. Cancer Res. 2004, 64:612-621.
30. Massague J., Gomis R.R. The logic of TGFbeta signaling. FEBS Lett. 2006, 580:2811-2820.
31. Nouet S., et al. Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J. Biol. Chem. 2004, 279:28989-28997.
32. Oberauer R., Rist W., Lenter M.C., Hamilton B.S., Neubauer H. EGFL6 is increasingly expressed in human obesity and promotes proliferation of adipose tissue-derived stromal vascular cells. Mol. Cell. Biochem. 2010, 343:257-269.
33. Riser B.L., et al. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease. Am. J. Pathol. 2009, 174:1725-1734.
34. Rosenbloom J., Castro S.V., Jimenez S.A. Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies. Ann Intern Med 2010, 152:159-166.
35. Sampson N., et al. ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma. Mol. Endocrinol. 2011, 25:503-515.
36. Serini G., Gabbiana G. Modulation of alpha-smooth muscle actin expression in fibroblasts by transforming growth factor-beta isoforms: an in vivo and in vitro study. Wound Repair Regen. 1996, 4:278-287.
37. Sheppard D. Integrin-mediated activation of latent transforming growth factor beta. Cancer Metastasis Rev. 2005, 24:395-402.
38. Swaney J.S., Roth D.M., Olson E.R., Naugle J.E., Meszaros J.G., Insel P.A. Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:437-442.
39. Takeda H., Katagata Y., Hozumi Y., Kondo S. Effects of angiotensin II receptor signaling during skin wound healing. Am. J. Pathol. 2004, 165:1653-1662.
40. Timmons J.A., et al. Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:4401-4406.
41. Wang D.Z., Olson E.N. Control of smooth muscle development by the myocardin family of transcriptional coactivators. Curr. Opin. Genet. Dev. 2004, 14:558-566.
42. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 2003, 83:835-870.
43. Wynn T.A., Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin. Liver Dis. 2010, 30:245-257.
44. Zhou H.M., Wang J., Elliott C., Wen W., Hamilton D.W., Conway S.J. Spatiotemporal expression of periostin during skin development and incisional wound healing: lessons for human fibrotic scar formation. J. Cell Commun. Signal. 2010, 4:99-107.